Performance of Determine Combo and other point-of-care HIV tests among Seattle MSM

Journal of Clinical Virology

Volumn 76, Issue , 2016, Pages 8-13

  Stekler, Joanne D ^a,b   Ure, George ^a   O'Neal, Joshua D ^c   Lane, Aric ^b   Swanson, Fred ^d   Maenza, Janine ^a   Stevens, Claire ^a   Coombs, Robert W ^a   Dragavon, Joan ^a   Swenson, Paul D ^b   Golden, Matthew R ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c SAN FRANCISCO AIDS FOUNDATION   (United States)

^d Gay City Health Project   (United States)

Author keywords

Background; HIV testing; Oral fluids; Rapid HIV test

Indexed keywords

DIAGNOSTIC KIT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACUTE DISEASE; ADULT; BLOOD; DIAGNOSTIC KIT; HIV INFECTIONS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INCIDENCE; MALE; MALE HOMOSEXUALITY; MASS SCREENING; MIDDLE AGED; POINT OF CARE SYSTEM; SALIVA; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; STANDARDS; VIROLOGY; WASHINGTON;

ACUTE DISEASE; ADULT; AIDS SERODIAGNOSIS; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; POINT-OF-CARE SYSTEMS; REAGENT KITS, DIAGNOSTIC; SALIVA; SENSITIVITY AND SPECIFICITY; WASHINGTON;

EID: 84958172910     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.12.011     Document Type: Article

References (31)

1. Fiebig E.W., Wright D.J., Rawal B.D., Garrett P.E., Schumacher R.T., Peddada L., et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003, 17:1871-1879.
2. Powers K.A., Ghani A.C., Miller W.C., Hoffman I.F., Pettifor A.E., Kamanga G., et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe Malawi: a modelling study. Lancet 2011, 378:256-268.
3. Hollingsworth T.D., Pilcher C.D., Hecht F.M., Deeks S.G., Fraser C. High transmissibility during early HIV infection among men who have sex with men-San Francisco, California. J. Infect. Dis. 2014, 211:1757-1760. ISSN:0022-1899.
4. Schacker T., Collier A.C., Hughes J., Shea T., Corey L. Clinical and epidemiologic features of primary HIV infection. Ann. Intern. Med. 1996, 125:257-264.
5. Stekler J.D., Baldwin H.D., Louella M.W., Katz D.A., Golden M.R. ru2hot? A public health education campaign for men who have sex with men to increase awareness of symptoms of acute HIV infection. Sex Transm. Infect. 2013, (August (5)):409-414. PMCID: PMC4257701.
6. Stekler J., Swenson P.D., Wood R.W., Handsfield H.H., Golden M.R. Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. AIDS 2005, 19:1323-1325.
7. Pilcher C.D., Fiscus S.A., Nguyen T.Q., Foust E., Wolf L., Williams D., et al. Detection of acute infections during HIV testing in North Carolina. N. Engl. J. Med. 2005, 352:1873-1883.
8. Klausner J.D., Grant R.M., Kent C.K. Detection of acute HIV infections. N. Engl. J. Med. 2005, 353:631-633.
9. Priddy F.H., Pilcher C.D., Moore R.H., Tambe P., Park M.N., Fiscus S.A., et al. Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J. Acquir. Immune Defic. Syndr. 2007, 44:196-202.
10. Masciotra S., McDougal J.S., Feldman J., Sprinkle P., Wesolowski L., Owen S.M. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections. J. Clin. Virol. 2011, 52(Suppl. 1):S17-22.
11. Stekler J.D., Swenson P.D., Coombs R.W., Dragavon J., Thomas K.K., Brennan C.A., et al. HIV testing in a high-incidence population: is antibody testing alone good enough?. Clin. Infect. Dis. 2009, 49:444-453.
12. Chavez P., Wesolowski L., Patel P., Delaney K., Owen S.M. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo assay. J. Clin. Virol. 2011, 52(Suppl. 1):S51-S55.
13. Pandori M.W., Hackett J., Louie B., Vallari A., Dowling T., Liska S., et al. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting. J. Clin. Microbiol. 2009, 47:2639-2642.
14. Patel P., Bennett B., Sullivan T., Parker M.M., Heffelfinger J.D., Sullivan P.S., et al. Rapid HIV screening: missed opportunities for HIV diagnosis and prevention. J. Clin. Virol. 2012, 54:42-47.
15. Pilcher C.D., Louie B., Facente S., Keating S., Hackett J., Vallari A., et al. Performance of rapid point-of-care and laboratory tests for acute and established HIV infection in San Francisco. PLoS One 2013, 8:e80629.
16. Masciotra S., Luo W., Youngpairoj A.S., Kennedy M.S., Wells S., Ambrose K., et al. Performance of the Alere Determine HIV-1/2 Ag/Ab Combo Rapid Test with specimens from HIV-seroconverters from the US and HIV-infected individuals from Ivory Coast. J. Clin. Virol. 2013, 58(Suppl. 1):e54-58.
17. Rosenberg N.E., Kamanga G., Phiri S., Nsona D., Pettifor A., Rutstein S.E., et al. Detection of acute HIV infection: a field evaluation of the determine(R) HIV-1/2 Ag/Ab combo test. J. Infect. Dis. 2012, 205:528-534.
18. Duong Y.T., Mavengere Y., Patel H., Moore C., Manjengwa J., Sibandze D., et al. Poor performance of the determine HIV-1/2 Ag/Ab Combo fourth-generation rapid test for detection of acute infections in a National Household Survey in Swaziland. J. Clin. Microbiol. 2014, 52:3743-3748.
19. Conway D.P., Holt M., McNulty A., Couldwell D.L., Smith D.E., Davies S.C., et al. Multi-centre evaluation of the Determine HIV Combo assay when used for point of care testing in a high risk clinic-based population. PLoS One 2014, 9:e94062.
20. O'Neal J.D., Golden M.R., Branson B.M., Stekler J.D. HIV nucleic acid amplification testing versus rapid testing: it is worth the wait. Testing preferences of men who have sex with men. J. Acquir. Immune Defic. Syndr. 2012, 60:e117-e120.
21. Stekler J.D., O'Neal J.D., Lane A., Swanson F., Maenza J., Stevens C.E., et al. Relative accuracy of serum, whole blood, and oral fluid HIV tests among Seattle men who have sex with men. J. Clin. Virol. 2013, 58(Suppl. 1):e119-e122.
22. Stekler J.D., Wellman R., Holte S., Maenza J., Stevens C.E., Corey L., et al. Are there benefits to starting antiretroviral therapy during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group. Int. J. STD AIDS 2012, 23:201-206.
23. Katz D.A., Dombrowski J.C., Swanson F., Buskin S.E., Golden M.R., Stekler J.D. HIV intertest interval among MSM in King County, Washington. Sex. Transm. Infect. 2013, 89:32-37.
24. Hutchinson A.B., Branson B.M., Kim A., Farnham P.G. A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status. AIDS 2006, 20:1597-1604.
25. Spielberg F., Branson B.M., Goldbaum G.M., Lockhart D., Kurth A., Rossini A., et al. Choosing, counseling and testing strategies for outreach settings: a randomized trial. J. Acquir. Immune Defic. Syndr. 2005, 38:348-355.
26. Keller S., Jones J., Erbelding E. Choice of rapid HIV testing and entrance into care in Baltimore city sexually transmitted infections clinics. AIDS Patient Care STDS 2011, 25:237-243.
27. Delaney K., Knoble T., Rurangirwa J., Facente S., Janson M., Scheer S., et al. Using a rapid HIV testing algorithm to improve the accuracy of HIV testing, receipt of test results, and linkage to care: results of a demonstration project in 2 US cities. In: 18th Conference on Retroviruses and Opportunistic Infections 2016, [abstract #132LB].
28. Detection of acute HIV infection in two evaluations of a new HIV diagnostic testing algorithm-United States, 2011-2013. MMWR Morb Mortal Wkly Rep 2013,62: 489-494.
29. Jani I.V., Meggi B., Mabunda N., Vubil A., Sitoe N.E., Tobaiwa O., et al. Accurate early infant HIV diagnosis in primary health clinics using a point-of-care nucleic acid test. J. Acquir. Immune Defic. Syndr. 2014, 67:e1-4.
30. Liegler T., Abdel-Mohsen M., Bentley L.G., Atchison R., Schmidt T., Javier J., et al. HIV-drug resistance in the iPrEx preexposure prophylaxis trial. J. Infect. Dis. 2014, 210:1217-1227.
31. Lehman D.A., Baeten J.M., McCoy C.O., Weis J.F., Peterson D., Mbara G., et al. Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent pre-exposure prophylaxis. J. Infect. Dis. 2015, 211:1211-1218.